[Form 4] Incyte Genomics Inc Insider Trading Activity

Rhea-AI Filing Summary

Lionsgate Studios Corp. (LION) – Form 4 insider filing: Chief Operating Officer Brian Goldsmith reported four equity transactions dated 1 July 2025.

• Equity grant: 256,024 common shares were awarded at $0 cost (85 % of the target annual equity award under his employment agreement).
• Performance-based vesting: 46,148 common shares were issued upon vesting of 75 % of previously granted performance RSUs.
• Tax withholding: To satisfy statutory tax obligations, the issuer automatically canceled 31,245 shares at $5.81 and 23,434 shares at $5.76 (coded “F”).
• Post-transaction ownership: Goldsmith now directly holds 1,528,026 common shares, including multiple layers of unvested RSUs scheduled to vest through 2028.

The filing reflects continued equity-based compensation and insider alignment but does not involve open-market buying or selling beyond tax-related cancellations. No derivative securities were reported.

Positive

• Increased insider ownership: COO’s direct holdings rose to 1.53 million shares, signalling continued long-term alignment with shareholders.

Negative

• Share dilution: Issuance of 302k new shares (grant + vesting) and 54.7k shares withheld for taxes marginally increases float, a slight dilutive effect.

Insights

Equity Compensation Analyst

TL;DR: Routine RSU vesting and new grant; minimal market impact.

The COO received a sizeable annual RSU grant (256k shares) and saw 75 % of a prior performance grant vest, increasing his beneficial ownership to 1.53 million shares. Shares withheld for taxes were settled in stock at prevailing prices (~$5.8), creating a small increase in float but not an open-market sale. Because the transactions are compensation-related and represent less than 1 % of estimated shares outstanding, I view the event as neutral for valuation yet modestly positive for insider alignment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Issa Mohamed Khairie

(Last) (First) (Middle)

1801 AUGUSTINE CUT-OFF

(Street)

WILMINGTON DE 19803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Head of US Oncology

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2025		A		27,812(1)	A	$0	76,483(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years from the vesting commencement date of January 6, 2025. The RSUs may be settled only for shares of common stock on a one-for-one basis.

2. Including the June 30, 2025 grant, this includes an aggregate of 76,483 shares of common stock issuable pursuant to previously reported RSUs that have not vested.

Remarks:

	/s/ Elizabeth Feeney, Attorney-In-Fact	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did COO Brian Goldsmith acquire in the July 1 2025 Form 4 for LION?

He received 256,024 new RSUs and 46,148 shares from vesting performance RSUs.

How many Lionsgate Studios shares does Brian Goldsmith now own?

After the reported transactions he directly holds 1,528,026 common shares.

Were any shares sold on the open market?

No. The only disposals (31,245 and 23,434 shares) were automatic cancellations to cover tax withholding, not open-market sales.

What prices were used for the tax-withholding share cancellations?

Shares were canceled at $5.81 and $5.76, reflecting the stock’s market price on July 1 2025.

When will the newly granted RSUs vest?

The 256,024 RSUs will vest in three equal tranches on July 1 of 2026, 2027 and 2028.